Protagenic Therapeutics, Inc. (PTIXW) NASDAQ
0.02
-0.001(-6.25%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.02
-0.001(-6.25%)
Currency In USD
Address
149 Fifth Avenue
New York City, NY 10010
United States of America (the)
Phone
212 994 8200
Website
Sector
Healthcare
Industry
Biotechnology
Employees
1
First IPO Date
April 27, 2021
| Name | Title | Pay | Year Born |
| Alexander Kenneth Arrow | Chief Financial Officer | 0 | 1971 |
| Robert Benjamin Stein | Chief Medical Officer | 0 | 1951 |
| William Nichols Jr. | President | 0 | 1975 |
| Garo H. Armen | Executive Chairman | 0 | 1953 |
Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company was founded in 2016 and is based in New York, New York.